CN114377108A - Oral liquid, sea cucumber and cordyceps peptide - Google Patents
Oral liquid, sea cucumber and cordyceps peptide Download PDFInfo
- Publication number
- CN114377108A CN114377108A CN202210081746.4A CN202210081746A CN114377108A CN 114377108 A CN114377108 A CN 114377108A CN 202210081746 A CN202210081746 A CN 202210081746A CN 114377108 A CN114377108 A CN 114377108A
- Authority
- CN
- China
- Prior art keywords
- percent
- sea cucumber
- cordyceps
- oral liquid
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000251511 Holothuroidea Species 0.000 title claims abstract description 133
- 239000007788 liquid Substances 0.000 title claims abstract description 109
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 62
- 241000190633 Cordyceps Species 0.000 title claims abstract description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 57
- 210000003734 kidney Anatomy 0.000 claims abstract description 54
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 45
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 45
- 235000008434 ginseng Nutrition 0.000 claims abstract description 45
- 239000002994 raw material Substances 0.000 claims abstract description 31
- 235000017784 Mespilus germanica Nutrition 0.000 claims abstract description 30
- 244000182216 Mimusops elengi Species 0.000 claims abstract description 30
- 235000000560 Mimusops elengi Nutrition 0.000 claims abstract description 30
- 241001248610 Ophiocordyceps sinensis Species 0.000 claims abstract description 30
- 235000007837 Vangueria infausta Nutrition 0.000 claims abstract description 30
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims abstract description 28
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000001768 carboxy methyl cellulose Substances 0.000 claims abstract description 28
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 claims abstract description 28
- 235000010241 potassium sorbate Nutrition 0.000 claims abstract description 28
- 239000004302 potassium sorbate Substances 0.000 claims abstract description 28
- 229940069338 potassium sorbate Drugs 0.000 claims abstract description 28
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims abstract description 28
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims abstract description 28
- 235000015278 beef Nutrition 0.000 claims abstract description 5
- 241000208340 Araliaceae Species 0.000 claims description 44
- 239000003814 drug Substances 0.000 claims description 34
- 238000011049 filling Methods 0.000 claims description 30
- 102000004190 Enzymes Human genes 0.000 claims description 29
- 108090000790 Enzymes Proteins 0.000 claims description 29
- 240000002948 Ophiopogon intermedius Species 0.000 claims description 29
- 238000004821 distillation Methods 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 238000002791 soaking Methods 0.000 claims description 20
- 238000010438 heat treatment Methods 0.000 claims description 19
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 230000008569 process Effects 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 14
- 238000001816 cooling Methods 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 12
- 229910052571 earthenware Inorganic materials 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 12
- 238000010411 cooking Methods 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 238000000605 extraction Methods 0.000 claims description 9
- 241000675108 Citrus tangerina Species 0.000 claims description 8
- 238000007710 freezing Methods 0.000 claims description 7
- 230000008014 freezing Effects 0.000 claims description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 6
- 235000015468 Lycium chinense Nutrition 0.000 claims description 6
- 229910052799 carbon Inorganic materials 0.000 claims description 6
- 238000009417 prefabrication Methods 0.000 claims description 6
- 244000241872 Lycium chinense Species 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 235000016357 Mirtillo rosso Nutrition 0.000 claims description 2
- 244000077923 Vaccinium vitis idaea Species 0.000 claims description 2
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 claims description 2
- 210000002421 cell wall Anatomy 0.000 claims description 2
- 230000000415 inactivating effect Effects 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 6
- 230000036541 health Effects 0.000 abstract description 3
- 229920001184 polypeptide Polymers 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 27
- 239000000686 essence Substances 0.000 description 21
- 239000000126 substance Substances 0.000 description 18
- 238000005516 engineering process Methods 0.000 description 9
- 230000001737 promoting effect Effects 0.000 description 9
- 230000001105 regulatory effect Effects 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 238000010298 pulverizing process Methods 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 108091005804 Peptidases Proteins 0.000 description 4
- 239000004365 Protease Substances 0.000 description 4
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000004332 deodorization Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 3
- 229920002683 Glycosaminoglycan Polymers 0.000 description 3
- 244000241838 Lycium barbarum Species 0.000 description 3
- 235000015459 Lycium barbarum Nutrition 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 230000002358 autolytic effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 229930188089 Holothurin Natural products 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 102000019197 Superoxide Dismutase Human genes 0.000 description 2
- 108010012715 Superoxide dismutase Proteins 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 238000006555 catalytic reaction Methods 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 239000000110 cooling liquid Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003292 glue Substances 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- MAWWITJOQDJRJF-ADBICINLSA-M holothurin Chemical compound [Na+].O[C@@H]1[C@@H](OC)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H](OC[C@H]([C@@H]3O)OS([O-])(=O)=O)O[C@@H]3C([C@H]4[C@](C=5[C@H]([C@@]6(CC[C@]7(O)[C@](C)([C@H]8OC(C)(C)CC8)OC(=O)[C@@]76[C@@H](O)C=5)C)CC4)(C)CC3)(C)C)O[C@@H]2C)O)O[C@H](C)[C@H]1O MAWWITJOQDJRJF-ADBICINLSA-M 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229960003080 taurine Drugs 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000965254 Apostichopus japonicus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000015463 Lycium carolinianum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 235000021167 banquet Nutrition 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000005842 biochemical reaction Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- -1 calcium Chemical class 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019249 food preservative Nutrition 0.000 description 1
- 239000005452 food preservative Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 230000002584 immunomodulator Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000021095 non-nutrients Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 210000000697 sensory organ Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000009967 tasteless effect Effects 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000001131 transforming effect Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Endocrinology (AREA)
- Developmental Biology & Embryology (AREA)
- Reproductive Health (AREA)
Abstract
The invention relates to the technical field of health care products and discloses an oral liquid sea cucumber cordyceps peptide which is prepared from the following raw materials in percentage by weight: the sea cucumber polypeptide preparation comprises 25-35% of sea cucumber, 7-13% of medlar, 3-7% of beef kidney, 3-7% of ginseng, 3-7% of radix ophiopogonis, 0.5-2% of dried orange peel, 0.1-0.5% of xylo-oligosaccharide, 0.15-0.05% of sodium carboxymethyl cellulose, 00.15-0.05% of potassium sorbate, 0.1-0.3% of cordyceps sinensis and 40-60% of pure water.
Description
Technical Field
The invention belongs to the technical field of health care products, and particularly relates to an oral liquid, namely sea cucumber cordyceps peptide.
Background
Essence is an essence formed by fusion of life substances of innate parents and acquired food essence, is the origin of human life, is all useful life substances in the human body, is the most basic substance for forming and maintaining human life activities, and is the essence by the biological peptide.
It is kept secret and kept secret, and is yin-nourishing compared with qi's movement. Essence has the important function of life reproduction, and also has the functions of nourishing, transforming blood, regulating qi, and refreshing mind. Essence can moisten and nourish the viscera, body constituents, sense organs and orifices of the human body. The innate essence and acquired essence are abundant, so that the zang-fu organs and kidneys are also abundant, so that the zang-fu organs, organs and orifices of the whole body are nourished and various physiological functions can be performed normally. If innate essence deficiency or acquired essence is obstructed, the essence deficiency of zang-fu organs will lose its nourishing effect, and the viscera tissues and orifices will not be nourished or supported by essence, and the function will fail to be performed normally, even decline. If kidney essence is damaged, growth and development are retarded or premature senility is observed.
The more enzymes in a human body are, the more complete the enzyme is, the healthier the life is, when no active enzyme exists in a human body, the life is finished, most of human diseases are related to enzyme deficiency or synthesis obstacle, the biological enzymolysis technology can enable a substance extract to be rich in active enzyme and promote metabolism of the human body, but the existing sea cucumber peptide is easy to extract and difficult to preserve activity, and therefore the oral liquid sea cucumber cordyceps peptide is provided.
Disclosure of Invention
The invention aims to solve the problems in the prior art and provides an oral liquid sea cucumber cordyceps peptide.
In order to achieve the purpose, the invention provides the following technical scheme:
an oral liquid sea cucumber cordyceps peptide is composed of the following raw materials in percentage by weight: comprises 25 to 35 percent of sea cucumber, 7 to 13 percent of medlar, 3 to 7 percent of cowberry kidney, 3 to 7 percent of ginseng, 3 to 7 percent of dwarf lilyturf tuber, 0.5 to 2 percent of dried orange peel, 0.1 to 0.5 percent of xylo-oligosaccharide, 0.15 to 0.05 percent of sodium carboxymethyl cellulose, 00.15 to 0.05 percent of potassium sorbate, 0.1 to 0.3 percent of cordyceps sinensis and 40 to 60 percent of pure water.
The production of the oral liquid, namely the sea cucumber cordyceps peptide comprises the following steps;
s1: preparing raw materials: selecting 25-35% of sea cucumber, 7-13% of medlar, 3-7% of beef kidney, 3-7% of ginseng, 3-7% of dwarf lilyturf tuber, 0.5-2% of dried orange peel, 0.1-0.5% of xylo-oligosaccharide, 0.1-0.5% of sodium carboxymethyl cellulose, 0.1-0.5% of potassium sorbate, 0.1-0.3% of cordyceps sinensis and 40-60% of pure water for prefabrication.
S2: enzymolysis of sea cucumber peptide; soaking fresh sea cucumber in clear water for 12-24h, wherein the clear water needs to be replaced for 3-5 times in the sea cucumber soaking process, after the sea cucumber soaking process is finished, high-pressure cooking is carried out, the sea cucumber and pure water are placed in a high-pressure cooker, the temperature of the high-pressure cooker is 130-, adding 17% of active carbon of dry matter weight for removing odor after enzymolysis, adding NaOH to adjust pH to 6.0-7.0, heating, inactivating enzyme, sterilizing, cooling to 70-75 deg.C, standing for 4 hr, adding Cordyceps to obtain sea cucumber peptide, and freezing at ultralow temperature to break cell wall;
s3: processing medicinal materials, namely respectively placing the ox kidney, the dried orange peel, the ginseng and the dwarf lilyturf tuber in a crushing device for crushing, placing the human participation dwarf lilyturf tuber in an earthenware pot after crushing, soaking the ginseng and the dwarf lilyturf tuber in the earthenware pot for 10-20min, simultaneously placing the ox kidney in the earthenware pot after pre-rinsing, heating the earthenware pot after the ox kidney is immersed in water at the heating temperature of 100 ℃ and 120 ℃ for 0.5-1.5h, placing the Chinese wolfberry in the earthenware pot after heating to 0.5h, obtaining Chinese medicinal liquid after heating the ox kidney, the ginseng, the dwarf lilyturf tuber and the Chinese wolfberry to obtain Chinese medicinal liquid, placing the Chinese medicinal liquid in the earthenware pot in a distillation device, processing the Chinese medicinal liquid in the distillation device, collecting the Chinese medicinal liquid in the ware pot after distillation processing, placing the collected Chinese medicinal liquid in a pressure cooker for high-pressure extraction work, the concentration and the drug property of the traditional Chinese medicine liquid are improved;
s4: and (3) filling the oral liquid, namely filling the medicinal materials, namely putting the concentrated Chinese medicinal liquid in the S3, the xylo-oligosaccharide, the sodium carboxymethyl cellulose and the potassium sorbate in the S1, the sea cucumber peptide in the S2 and the concentrated Chinese medicinal liquid in the S3 into a filling machine, and mixing the raw materials through the mixing in the filling machine to finish the filling work of the raw materials to obtain the oral liquid.
Preferably, the sea cucumber in the S1 is fresh sea cucumber, and when the sea cucumber is used, the sea cucumber needs to spit sand in clear water, so that the quality and the drug property of the oral liquid are prevented from being influenced in the processing process.
Preferably, the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 33 percent of sea cucumber, 7 percent of medlar, 3 percent of ox kidney, 7 percent of ginseng, 3 percent of dwarf lilyturf tuber, 2 percent of tangerine peel, 0.5 percent of xylo-oligosaccharide, 0.05 percent of sodium carboxymethyl cellulose, 0.05 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 43.2 percent of pure water.
Preferably, the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 35% of sea cucumber, 7% of medlar, 3% of ox kidney, 3% of ginseng, 3% of dwarf lilyturf tuber, 2% of dried orange peel, 0.3% of xylo-oligosaccharide, 0.15% of sodium carboxymethyl cellulose, 0.15% of potassium sorbate, 0.2% of cordyceps sinensis and 46.2% of pure water.
Preferably, the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 30% of sea cucumber, 10% of medlar, 5% of ox kidney, 5% of ginseng, 5% of dwarf lilyturf tuber, 1% of dried orange peel, 0.3% of xylo-oligosaccharide, 0.1% of sodium carboxymethyl cellulose, 0.1% of potassium sorbate, 0.2% of cordyceps sinensis and 43.3% of pure water.
Preferably, the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 25 percent of sea cucumber, 13 percent of medlar, 6 percent of ox kidney, 7 percent of ginseng, 7 percent of dwarf lilyturf tuber, 0.5 percent of tangerine peel, 0.5 percent of xylo-oligosaccharide, 0.1 percent of sodium carboxymethyl cellulose, 0.1 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 40.6 percent of pure water.
Compared with the prior art, the invention provides the oral liquid sea cucumber cordyceps peptide, which has the following beneficial effects:
1. the traditional Chinese medicine formula of the invention has the effects of supplementing qi and nourishing yin, is supported by the traditional Chinese medicine liquid, can well preserve the activity of the sea cucumber peptide, can be absorbed within one minute on an empty stomach, can directly absorb the sea cucumber peptide without digestion, and can tonify the kidney, provide high-quality protein which is higher in quality and easier to absorb for a human body, and in order to more reasonably and effectively utilize the components of the medicinal materials, the sea cucumber peptide of the formula is processed and produced by adopting a biological enzymolysis technology, and other medicinal materials are processed and produced by adopting a multi-stage separation and high-pressure extraction technology, and according to different parts and properties of the related medicinal materials, three extraction processes of conventional decoction, distillation separation and high-pressure extraction are respectively adopted to obtain 4 kinds of extracts, and finally the extracts are synthesized;
2. the formula of the formula after compatibility is clear in major and minor, has a clean and reasonable structure, has the effects of tonifying kidney, replenishing vital essence and resisting aging by reusing the sea cucumber, the medlar and the ox kidney extract, and has the advantages of respective emphasis, so that the whole formula mainly replenishes essence, has the effects of nourishing yin and blood, and tonifying but not greasy, and is free of deficiency; the ginseng and the dwarf lilyturf tuber have the effects of supplementing qi and nourishing yin, and provide nutrient substances which are particularly urgently needed by a human body; the dried orange peel can regulate qi, invigorate spleen and govern spleen transportation and transformation, so that the formula essences are better absorbed, and the dried orange peel can quickly tonify kidney and replenish essence: the radix ophiopogonis can timely supplement water to the skin which is short of body fluid (commonly called water), and delay aging, and the formula is safe and effective and can be completely used as a daily health-care beverage;
3. the product has the core effects of tonifying qi and blood, tonifying kidney and replenishing essence, and is tried by more than 100 volunteers, one adverse reaction does not occur, the regular tracking and feedback after the product is taken, the sleep quality is improved, the immunity is enhanced, the complexion is ruddy and glossy, and the like.
Drawings
The accompanying drawings, which are included to provide a further understanding of the invention and are incorporated in and constitute a part of this specification, illustrate embodiments of the invention and together with the description serve to explain the principles of the invention and not to limit the invention.
In the drawings:
FIG. 1 is a production flow chart of the oral liquid sea cucumber cordyceps peptide provided by the invention.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the drawings in the embodiments of the present invention, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all of the embodiments; all other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
Example 1:
referring to fig. 1, an oral liquid of sea cucumber cordyceps peptide is composed of the following raw materials by weight: comprises 33 percent of sea cucumber, 7 percent of medlar, 3 percent of ox kidney, 7 percent of ginseng, 3 percent of dwarf lilyturf tuber, 2 percent of tangerine peel, 0.5 percent of xylo-oligosaccharide, 0.05 percent of sodium carboxymethyl cellulose, 0.05 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 43.4 percent of pure water.
The production of the oral liquid, namely the sea cucumber cordyceps peptide, comprises the following steps;
s1: preparing raw materials: selecting 33% of sea cucumber, 7% of medlar, 3% of ox kidney, 7% of ginseng, 3% of dwarf lilyturf tuber, 2% of dried orange peel, 0.5% of xylo-oligosaccharide, 0.05% of sodium carboxymethyl cellulose, 0.05% of potassium sorbate, 0.2% of cordyceps sinensis and 43.4% of pure water for prefabrication.
S2: enzymolysis of sea cucumber peptide; soaking fresh sea cucumbers in clean water for 12 hours, wherein the clean water needs to be replaced for 3 times in the sea cucumber soaking process, after the sea cucumbers are soaked, high-pressure cooking is carried out, the sea cucumbers and pure water are placed in a high-pressure pot, the temperature of the high-pressure pot is 1150 ℃, the cooking time of the high-pressure pot is 1.5 hours, the sea cucumber extracting solution is filtered and then placed in a cooling tank for cooling, after the sea cucumber cooling solution is cooled, soluble compound protease is added for enzymolysis, the enzymolysis condition is pH8.0, the temperature is 40 ℃, the time is 5 hours, after the enzymolysis is finished, active carbon with 17 percent of the weight of dry matter is added for deodorization, then NaOH is added for regulating the pH value to be 6.0, after the temperature is raised, the enzyme is inactivated and the sterilization is carried out, the temperature is reduced to 75 ℃, the standing is carried out for 4 hours, cordyceps sinensis is added to obtain sea cucumber peptides, and the cordyceps sinensis is subjected to wall breaking by using an ultralow temperature freezing technology;
s3: processing the raw materials, respectively placing ren bovis Seu Bubali, pericarpium Citri Tangerinae, Ginseng radix and radix Ophiopogonis in a pulverizing device, pulverizing, placing radix Ginseng and radix Ophiopogonis in a casserole, soaking Ginseng radix and radix Ophiopogonis in cold water for 20min, meanwhile, the ox kidney is placed in the earthen pot after being pre-watered, the ox kidney is heated after being watered, the heating temperature is 120 ℃, the heating time is 1h, the medlar is placed in the earthen pot after being heated to 0.5h, the ox kidney, the ginseng, the dwarf lilyturf tuber and the medlar are heated to obtain the traditional Chinese medicine liquid, the traditional Chinese medicine liquid in the earthen pot is placed in a distillation device, processing the Chinese medicinal liquid by distillation device, collecting the Chinese medicinal liquid in the casserole after distillation, placing the collected Chinese medicinal liquid in a pressure cooker, the traditional Chinese medicine liquid in the casserole is extracted under high pressure by a pressure cooker, so that the concentration and the drug property of the traditional Chinese medicine liquid are improved;
s4: and (3) filling the oral liquid, namely filling the medicinal materials, namely putting the concentrated Chinese medicinal liquid in the S3, the xylo-oligosaccharide, the sodium carboxymethyl cellulose and the potassium sorbate in the S1, the sea cucumber peptide in the S2 and the concentrated Chinese medicinal liquid in the S3 into a filling machine, and mixing the raw materials through the mixing in the filling machine to finish the filling work of the raw materials to obtain the oral liquid.
S1, the sea cucumber is fresh and needs to be spitted in clear water when in use, so that the quality and the drug property of the oral liquid are prevented from being influenced in the processing process.
Example 2:
referring to fig. 1, an oral liquid of sea cucumber cordyceps peptide is composed of the following raw materials by weight: 35% of sea cucumber, 7% of medlar, 3% of ox kidney, 3% of ginseng, 3% of dwarf lilyturf tuber, 2% of dried orange peel, 0.3% of xylo-oligosaccharide, 0.15% of sodium carboxymethyl cellulose, 0.15% of potassium sorbate, 0.2% of cordyceps sinensis and 46.4% of pure water.
The production of the oral liquid, namely the sea cucumber cordyceps peptide, comprises the following steps;
s1: preparing raw materials: the preparation method comprises the steps of selecting 35% of sea cucumber, 7% of medlar, 3% of beef kidney, 3% of ginseng, 3% of radix ophiopogonis, 2% of dried orange peel, 0.3% of xylo-oligosaccharide, 0.15% of sodium carboxymethyl cellulose, 0.15% of potassium sorbate, 0.2% of cordyceps sinensis and 46.4% of pure water for prefabrication.
S2: enzymolysis of sea cucumber peptide; soaking fresh sea cucumbers in clean water for 24 hours, wherein the clean water needs to be replaced for 5 times in the sea cucumber soaking process, after the sea cucumbers are soaked, high-pressure cooking is carried out, the sea cucumbers and pure water are placed in a pressure cooker, the temperature of the pressure cooker is 150 ℃, the cooking time of the pressure cooker is 2 hours, the sea cucumber extracting solution is filtered and then placed in a cooling tank for cooling, after the sea cucumber cooling liquid is cooled, soluble compound protease is added for enzymolysis, the enzymolysis condition is pH9.0, the temperature is 40 ℃, the time is 5 hours, after the enzymolysis is finished, active carbon accounting for 17 percent of the weight of dry matter is added for deodorization, then NaOH is added for regulating the pH value to-7.0, after the temperature is raised, enzyme is inactivated and sterilized, the temperature is reduced to 75 ℃, standing is carried out for 4 hours, cordyceps sinensis is added to obtain sea cucumber peptides, and the cordyceps sinensis uses an ultralow temperature freezing wall breaking technology;
s3: processing the raw materials, respectively placing ren bovis Seu Bubali, pericarpium Citri Tangerinae, Ginseng radix and radix Ophiopogonis in a pulverizing device, pulverizing, placing radix Ginseng and radix Ophiopogonis in a casserole, soaking Ginseng radix and radix Ophiopogonis in cold water for 15min, meanwhile, the ox kidney is placed in the earthen pot after being pre-watered, the ox kidney is heated after being watered, the heating temperature is 110 ℃, the heating time is 1.5h, the medlar is placed in the earthen pot after being heated to 0.5h, the ox kidney, the ginseng, the radix ophiopogonis and the medlar are heated to obtain the traditional Chinese medicine liquid, the traditional Chinese medicine liquid in the earthen pot is placed in a distillation device, processing the Chinese medicinal liquid by distillation device, collecting the Chinese medicinal liquid in the casserole after distillation, placing the collected Chinese medicinal liquid in a pressure cooker, the traditional Chinese medicine liquid in the casserole is extracted under high pressure by a pressure cooker, so that the concentration and the drug property of the traditional Chinese medicine liquid are improved;
s4: and (3) filling the oral liquid, namely filling the medicinal materials, namely putting the concentrated Chinese medicinal liquid in the S3, the xylo-oligosaccharide, the sodium carboxymethyl cellulose and the potassium sorbate in the S1, the sea cucumber peptide in the S2 and the concentrated Chinese medicinal liquid in the S3 into a filling machine, and mixing the raw materials through the mixing in the filling machine to finish the filling work of the raw materials to obtain the oral liquid.
S1, the sea cucumber is fresh and needs to be spitted in clear water when in use, so that the quality and the drug property of the oral liquid are prevented from being influenced in the processing process.
Example 3:
referring to fig. 1, an oral liquid of sea cucumber cordyceps peptide is composed of the following raw materials by weight: comprises 30 percent of sea cucumber, 10 percent of medlar, 5 percent of ox kidney, 5 percent of ginseng, 5 percent of dwarf lilyturf tuber, 1 percent of dried orange peel, 0.3 percent of xylo-oligosaccharide, 0.1 percent of sodium carboxymethyl cellulose, 0.1 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 43.5 percent of pure water.
The production of the oral liquid, namely the sea cucumber cordyceps peptide, comprises the following steps;
s1: preparing raw materials: 30 percent of sea cucumber, 10 percent of medlar, 5 percent of ox kidney, 5 percent of ginseng, 5 percent of dwarf lilyturf tuber, 1 percent of tangerine peel, 0.3 percent of xylo-oligosaccharide, 0.1 percent of sodium carboxymethyl cellulose, 0.1 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 43.5 percent of pure water are selected for prefabrication.
S2: enzymolysis of sea cucumber peptide; soaking fresh sea cucumbers in clear water for 18 hours, wherein the clear water needs to be replaced 4 times in the sea cucumber soaking process, after the sea cucumbers are soaked, high-pressure cooking is carried out, the sea cucumbers and pure water are placed in a high-pressure pot, the temperature of the high-pressure pot is 140 ℃, the cooking time of the high-pressure pot is 2 hours, the sea cucumber extracting solution is filtered and then placed in a cooling tank for cooling, after the sea cucumber cooling liquid is cooled, soluble compound protease is added for enzymolysis, the enzymolysis condition is pH8.5, the temperature is 35 ℃, the time is 4 hours, after the enzymolysis is finished, active carbon accounting for 17 percent of the weight of dry matter is added for deodorization, then NaOH is added for regulating the pH to be 6.5, after the temperature is raised, enzyme is inactivated and sterilized, the temperature is reduced to 75 ℃, standing is carried out for 4 hours, cordyceps sinensis is added to obtain sea cucumber peptides, and the cordyceps sinensis uses an ultralow temperature freezing wall breaking technology;
s3: processing the raw materials, respectively placing ren bovis Seu Bubali, pericarpium Citri Tangerinae, Ginseng radix and radix Ophiopogonis in a pulverizing device, pulverizing, placing radix Ginseng and radix Ophiopogonis in a casserole, soaking Ginseng radix and radix Ophiopogonis in cold water for 15min, meanwhile, the ox kidney is placed in the earthen pot after being pre-watered, the ox kidney is heated after being watered, the heating temperature is 110 ℃, the heating time is 1.5h, the medlar is placed in the earthen pot after being heated to 0.5h, the ox kidney, the ginseng, the radix ophiopogonis and the medlar are heated to obtain the traditional Chinese medicine liquid, the traditional Chinese medicine liquid in the earthen pot is placed in a distillation device, processing the Chinese medicinal liquid by distillation device, collecting the Chinese medicinal liquid in the casserole after distillation, placing the collected Chinese medicinal liquid in a pressure cooker, the traditional Chinese medicine liquid in the casserole is extracted under high pressure by a pressure cooker, so that the concentration and the drug property of the traditional Chinese medicine liquid are improved;
s4: and (3) filling the oral liquid, namely filling the medicinal materials, namely putting the concentrated Chinese medicinal liquid in the S3, the xylo-oligosaccharide, the sodium carboxymethyl cellulose and the potassium sorbate in the S1, the sea cucumber peptide in the S2 and the concentrated Chinese medicinal liquid in the S3 into a filling machine, and mixing the raw materials through the mixing in the filling machine to finish the filling work of the raw materials to obtain the oral liquid.
S1, the sea cucumber is fresh and needs to be spitted in clear water when in use, so that the quality and the drug property of the oral liquid are prevented from being influenced in the processing process.
Example 4:
referring to fig. 1, an oral liquid of sea cucumber cordyceps peptide is composed of the following raw materials by weight: 25 percent of sea cucumber, 13 percent of medlar, 6 percent of ox kidney, 7 percent of ginseng, 7 percent of dwarf lilyturf tuber, 0.5 percent of tangerine peel, 0.5 percent of xylo-oligosaccharide, 0.1 percent of sodium carboxymethyl cellulose, 0.1 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 40.8 percent of pure water.
The production of the oral liquid, namely the sea cucumber cordyceps peptide, comprises the following steps;
s1: preparing raw materials: 25 percent of sea cucumber, 13 percent of medlar, 6 percent of ox kidney, 7 percent of ginseng, 7 percent of dwarf lilyturf tuber, 0.5 percent of tangerine peel, 0.5 percent of xylo-oligosaccharide, 0.1 percent of sodium carboxymethyl cellulose, 0.1 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 40.8 percent of pure water are selected for prefabrication.
S2: enzymolysis of sea cucumber peptide; soaking fresh sea cucumbers in clear water for 4 hours, wherein the clear water needs to be replaced for 5 times in the sea cucumber soaking process, after the sea cucumbers are soaked, high-pressure cooking is carried out, the sea cucumbers and pure water are placed in a pressure cooker, the temperature of the pressure cooker is 150 ℃, the cooking time of the pressure cooker is 2.5 hours, the sea cucumber extracting solution is filtered and then placed in a cooling tank for cooling, after the sea cucumber cooling solution is cooled, soluble compound protease is added for enzymolysis, the enzymolysis condition is pH8.7, the temperature is 34 ℃, the time is 3 hours, after the enzymolysis is finished, active carbon accounting for 17 percent of the weight of dry matter is added for deodorization, then NaOH is added for regulating the pH to be 6.7, after the temperature is raised, enzyme is inactivated and sterilized, the temperature is reduced to 72 ℃, standing is carried out for 4 hours, cordyceps sinensis is added to obtain sea cucumber peptides, and the cordyceps sinensis is subjected to wall breaking by using an ultralow temperature freezing technology;
s3: processing the raw materials, respectively placing ren bovis Seu Bubali, pericarpium Citri Tangerinae, Ginseng radix and radix Ophiopogonis in a pulverizing device, pulverizing, placing radix Ginseng and radix Ophiopogonis in a casserole, soaking Ginseng radix and radix Ophiopogonis in cold water for 15min, meanwhile, the ox kidney is placed in the earthen pot after being pre-watered, the ox kidney is heated after being watered, the heating temperature is 110 ℃, the heating time is 1.2h, the medlar is placed in the earthen pot after being heated to 0.5h, the ox kidney, the ginseng, the radix ophiopogonis and the medlar are heated to obtain the traditional Chinese medicine liquid, the traditional Chinese medicine liquid in the earthen pot is placed in a distillation device, processing the Chinese medicinal liquid by distillation device, collecting the Chinese medicinal liquid in the casserole after distillation, placing the collected Chinese medicinal liquid in a pressure cooker, the traditional Chinese medicine liquid in the casserole is extracted under high pressure by a pressure cooker, so that the concentration and the drug property of the traditional Chinese medicine liquid are improved;
s4: and (3) filling the oral liquid, namely filling the medicinal materials, namely putting the concentrated Chinese medicinal liquid in the S3, the xylo-oligosaccharide, the sodium carboxymethyl cellulose and the potassium sorbate in the S1, the sea cucumber peptide in the S2 and the concentrated Chinese medicinal liquid in the S3 into a filling machine, and mixing the raw materials through the mixing in the filling machine to finish the filling work of the raw materials to obtain the oral liquid.
S1, the sea cucumber is fresh and needs to be spitted in clear water when in use, so that the quality and the drug property of the oral liquid are prevented from being influenced in the processing process.
Clinical effects and observations
In four groups of embodiments of the invention, the oral liquid produced in the embodiment 3 has the highest quality, the drug effect is most suitable for users, the core effects of the formula product are tonifying qi and enriching blood, tonifying kidney and replenishing essence, the formula product is tried by more than 100 volunteers, no adverse reaction occurs, regular tracking feedback is carried out after taking, the sleep quality is improved, the immunity is enhanced, the complexion is ruddy and glossy, and the like.
Suitable for people and application
The peptide is an important substance for forming all cells and tissues of a human body, is warm, moist, nourishing and nutrient-supplementing from inside to outside, and is suitable for various crowds:
1. middle aged and elderly people group
2. People with weak body
3. Working group with high pressure and tired
4. Postoperative physical weakness
5. Pregnant and postpartum recovery population
6. Brain population for students at school
7. Children growth crowd
8. People with gastrointestinal discomfort
9. Sub-health office worker
The use method comprises the following steps: heating for 5min (water temperature can not exceed 70 deg.C), taking orally with open web, 15-25 ml each time, 1-3 times per day, and can be absorbed within one minute without digestion, and can directly absorb blood and kidney without digestion, thereby providing high quality protein with high quality and easy absorption for human body.
In order to more reasonably and effectively utilize the components of the medicinal materials, the sea cucumber peptide of the formula is processed and produced by adopting a biological enzymolysis technology and adopting a multi-stage separation and high-pressure extraction technology for other medicinal materials, three extraction processes of conventional decoction, distillation separation and high-pressure extraction are respectively adopted according to different parts and properties of the related medicinal materials to obtain 4 kinds of extracts, and finally the extracts are synthesized,
the biological enzymolysis technology is characterized in that a corresponding enzyme (usually hydrolase) is selected to decompose biomacromolecules in a polymer form into micromolecular proteins or polypeptides by utilizing the characteristic of high specificity of enzymatic reaction catalyzed by the biological enzyme, the biological enzymolysis technology has the advantages that substances are decomposed by the catalysis of the enzyme, the capability of enzymatic chemical reaction is called enzyme activity (or called enzyme activity), the enzyme activity can be regulated and controlled by various factors, so that an organism can adapt to the change of external conditions to maintain the life activity, the characteristics of different active ingredients of the substances are mastered by utilizing different catalysis of different enzymes, the active substances of the substances can be extracted, the traditional substance extraction adopts high-temperature continuous decomposition or low-temperature quick freezing, so that most of the active substances of the substances are destroyed, the activity of an extract is lost, the exertion of the efficacy is influenced, and the organism is composed of cells, each cell shows various life activities due to the existence of enzyme, the metabolism in vivo can be carried out, the enzyme is a catalyst of the metabolism in the human body, various biochemical reactions can be carried out in the human body only when the enzyme exists, the more the enzyme exists in the human body, the more complete the enzyme exists, the healthier the life is, when the active enzyme does not exist in the human body, the life is ended, and most of human diseases are related to enzyme deficiency or synthesis obstacle.
Sea cucumber is the first acknowledged 'eight delicacies in sea', is a big dish pressed on a high-grade banquet, is also an important tonic for health preservation and nourishing in traditional Chinese medicine, is a seafood which is rarely high in protein, low in fat and free of cholesterol on the earth, contains high-quality protein, rich vitamins and minerals and more than 60 nutrient substances needed by a human body, contains more than 50 and can be named as a natural nutrition treasure house, and the most precious part of the sea cucumber is a special non-nutrient substance-rare active substance contained in other bodies besides rich nutrition.
1. Sea cucumber autolytic enzyme
The sea cucumber autolytic enzyme is named as 'sea gold', and is an extremely precious substance which is not possessed by any other organisms. Practice proves that the sea cucumber autolytic enzyme can prevent and inhibit the formation of human thrombus, has obvious effect on the recovery of patients with coronary heart disease, myocardial infarction and cerebral thrombosis, and prevents and reduces the occurrence of cardiovascular and cerebrovascular diseases.
2. Sea cucumber acidic mucopolysaccharide
The sea cucumber acidic mucopolysaccharide is called 'gold in sea', is a high-efficiency immunomodulator, has a broad-spectrum anticancer effect, and is proved by medical researches: the sea cucumber acidic mucopolysaccharide has obvious curative effect on diabetic patients, can effectively reduce blood sugar and urine sugar, and can effectively inhibit the occurrence of diabetic complications.
3. Sea cucumber saponins
The sea cucumber contains a large amount of holothurin toxins in the viscera, body wall and glands, the toxins are also called holothurin, have obvious functions of promoting blood circulation and removing blood stasis, can reduce platelet coagulation, prevent the formation of venous embolism, and have obvious improvement effects on cerebral thrombosis, myocardial infarction recovery period and ischemic heart disease.
4. Chondroitin sulfate
Chondroitin sulfate is a substance required by construction and repair of human cartilage tissues, has a good promoting effect on generation of bones, ligaments and joint fluid, has a function of reconstructing damaged and aged soft tissues, can prevent cartilage abrasion, and has an obvious improving effect on senile arthritis and joint rheumatism.
5. Chitosan
Is the only animal cellulose with positive charges, positive ions and weak alkalinity in the universe. Regulating acid-base balance of human body, has strong functions of activating, repairing and regenerating cells, and can carry harmful substances and heavy metals away; improving the absorption of inorganic salts such as calcium, and improving the immunity of the organism.
6. Collagen protein
Is an important component in extracellular matrix, and the stichopus japonicus collagen can be compared with donkey-hide gelatin, tortoise-plastron glue, antler glue and the like in the traditional Chinese medicine on the components and the effects. Has good effects of promoting hematogenesis, nourishing blood and promoting calcium absorption; resisting tumor, eliminating inflammation, and improving immunity; maintaining beauty, keeping young, and restoring and enhancing skin elasticity.
SOD (superoxide dismutase)
Is an active substance originated from life, and can eliminate harmful substances generated in the metabolism process of human body; eliminating excessive free radicals, regulating immunity, delaying aging, regulating female physiological cycle, and postponing climacteric period.
8. Xanthophyll
Is a flavonoid substance, and is orange red. The vitamin can not be synthesized by human body like some essential vitamins, can effectively remove and inhibit eye free radicals, and has good effects of protecting eyes and restoring vision.
9. Specific amino acids
Taurine: taurine is a special amino acid essential for human body, and has effects of promoting the development of important organs such as brain (especially the development of infant brain), protecting liver and promoting bile flow.
(ii) arginine: also belongs to conditionally essential amino acids, the sea cucumber contains very rich arginine, called arginine "radix Rubi Parvifolii", which is the main raw material of spermatid and has important effects on repairing tissue injury and stress!
Wolfberry fruit: sweet, flat, boxthorn leaf: bitter and sweet, cool in nature, and functional: wolfberry fruit: nourishing liver, nourishing kidney, moistening lung, tonifying deficiency, replenishing vital essence, clearing heat and improving eyesight.
The beef kidney: has the effects of tonifying kidney, replenishing vital essence, strengthening waist and knee joints and relieving arthralgia, and is commonly used for consumptive disease and kidney deficiency, impotence, qi deficiency, soreness and weakness of waist and knees and damp arthralgia.
Ginseng: sweet and slightly bitter in taste, warm and mild in nature. It enters spleen, lung and heart meridians. Invigorating qi, relieving depletion, promoting fluid production, tranquilizing mind, improving intelligence, invigorating primordial qi, restoring pulse, relieving depletion, invigorating spleen, benefiting lung, promoting fluid production, and tranquilizing mind.
Radix ophiopogonis: nourish yin and generate fluid, moisten lung and relieve cough, it is indicated for scanty fluid and thirst due to yin deficiency of lung and stomach, cough and hemoptysis, palpitation due to heart yin deficiency, easy fright and body fluid impairment due to heat in later stage of fever, etc., and it is combined with Sha Shen and Chuan Bei to treat dryness due to lung yin deficiency.
And (3) xylo-oligosaccharide: the health-care product has the advantages of reducing the production of toxic fermentation products and harmful bacterial enzymes, inhibiting pathogenic bacteria and diarrhea, preventing constipation, protecting liver function, reducing serum cholesterol, reducing blood pressure, enhancing immunity of the organism, resisting cancer, having good compatibility, promoting the organism to generate various nutrient substances including vitamin B1, B2, B6, B12, nicotinic acid and folic acid, preventing and protecting dental caries and inhibiting the breeding of oral bacteria.
Sodium carboxymethyl cellulose: the cellulose derivative has a glucose polymerization degree of 100-2000, a relative molecular mass of 242.16, and is white fibrous or granular powder, odorless, tasteless, hygroscopic, and insoluble in organic solvents.
The potassium sorbate is colorless to white scale-shaped crystal or crystalline powder, has no smell or slight smell, is mainly used as a food preservative with a molecular structure, belongs to an acid preservative matched with organic acid to improve the preservative reaction effect, and is prepared by taking potassium carbonate or potassium hydroxide and sorbic acid as raw materials.
Pure water: the method refers to that water subjected to distillation and condensation operations is distilled twice, namely redistilled water, and is distilled three times, so that new impurities are not introduced.
It is noted that, herein, relational terms such as first and second, and the like may be used solely to distinguish one entity or action from another entity or action without necessarily requiring or implying any actual such relationship or order between such entities or actions. Also, the terms "comprises," "comprising," or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that comprises a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.
Claims (7)
1. An oral liquid sea cucumber cordyceps peptide is characterized in that: the oral liquid sea cucumber cordyceps peptide is prepared from the following raw materials in percentage by weight: comprises 25 to 35 percent of sea cucumber, 7 to 13 percent of medlar, 3 to 7 percent of cowberry kidney, 3 to 7 percent of ginseng, 3 to 7 percent of dwarf lilyturf tuber, 0.5 to 2 percent of dried orange peel, 0.1 to 0.5 percent of xylo-oligosaccharide, 0.15 to 0.05 percent of sodium carboxymethyl cellulose, 00.15 to 0.05 percent of potassium sorbate, 0.1 to 0.3 percent of cordyceps sinensis and 40 to 60 percent of pure water.
2. The oral liquid sea cucumber cordyceps peptide according to claim 1, which is characterized in that: the production of the oral liquid, namely the sea cucumber cordyceps peptide comprises the following steps; 0.2 percent of cordyceps sinensis,
s1: preparing raw materials: selecting 25-35% of sea cucumber, 7-13% of medlar, 3-7% of beef kidney, 3-7% of ginseng, 3-7% of dwarf lilyturf tuber, 0.5-2% of dried orange peel, 0.1-0.5% of xylo-oligosaccharide, 0.1-0.5% of sodium carboxymethyl cellulose, 0.1-0.5% of potassium sorbate, 0.1-0.3% of cordyceps sinensis and 40-60% of pure water for prefabrication.
S2: enzymolysis of sea cucumber peptide; soaking fresh sea cucumber in clear water for 12-24h, wherein the clear water needs to be replaced for 3-5 times in the sea cucumber soaking process, after the sea cucumber soaking process is finished, high-pressure cooking is carried out, the sea cucumber and pure water are placed in a high-pressure cooker, the temperature of the high-pressure cooker is 130-, adding 17% of active carbon of dry matter weight for removing odor after enzymolysis, adding NaOH to adjust pH to 6.0-7.0, heating, inactivating enzyme, sterilizing, cooling to 70-75 deg.C, standing for 4 hr, adding Cordyceps to obtain sea cucumber peptide, and freezing at ultralow temperature to break cell wall;
s3: processing medicinal materials, namely respectively placing the ox kidney, the dried orange peel, the ginseng and the dwarf lilyturf tuber in a crushing device for crushing, placing the human participation dwarf lilyturf tuber in an earthenware pot after crushing, soaking the ginseng and the dwarf lilyturf tuber in the earthenware pot for 10-20min, simultaneously placing the ox kidney in the earthenware pot after pre-rinsing, heating the earthenware pot after the ox kidney is immersed in water at the heating temperature of 100 ℃ and 120 ℃ for 0.5-1.5h, placing the Chinese wolfberry in the earthenware pot after heating to 0.5h, obtaining Chinese medicinal liquid after heating the ox kidney, the ginseng, the dwarf lilyturf tuber and the Chinese wolfberry to obtain Chinese medicinal liquid, placing the Chinese medicinal liquid in the earthenware pot in a distillation device, processing the Chinese medicinal liquid in the distillation device, collecting the Chinese medicinal liquid in the ware pot after distillation processing, placing the collected Chinese medicinal liquid in a pressure cooker for high-pressure extraction work, the concentration and the drug property of the traditional Chinese medicine liquid are improved;
s4: and (3) filling the oral liquid, namely filling the medicinal materials, namely putting the concentrated Chinese medicinal liquid in the S3, the xylo-oligosaccharide, the sodium carboxymethyl cellulose and the potassium sorbate in the S1, the sea cucumber peptide in the S2 and the concentrated Chinese medicinal liquid in the S3 into a filling machine, and mixing the raw materials through the mixing in the filling machine to finish the filling work of the raw materials to obtain the oral liquid.
3. The oral liquid sea cucumber cordyceps peptide according to claim 1, which is characterized in that: s1, the sea cucumber is fresh and needs to be spitted in clear water when in use, so that the quality and the drug property of the oral liquid are prevented from being influenced in the processing process.
4. The oral liquid sea cucumber cordyceps peptide according to claim 1, which is characterized in that: the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 33 percent of sea cucumber, 7 percent of medlar, 3 percent of ox kidney, 7 percent of ginseng, 3 percent of dwarf lilyturf tuber, 2 percent of tangerine peel, 0.5 percent of xylo-oligosaccharide, 0.05 percent of sodium carboxymethyl cellulose, 0.05 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 43.2 percent of pure water.
5. The oral liquid sea cucumber cordyceps peptide according to claim 1, which is characterized in that: the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 35% of sea cucumber, 7% of medlar, 3% of ox kidney, 3% of ginseng, 3% of dwarf lilyturf tuber, 2% of dried orange peel, 0.3% of xylo-oligosaccharide, 0.15% of sodium carboxymethyl cellulose, 0.15% of potassium sorbate, 0.2% of cordyceps sinensis and 46.2% of pure water.
6. The oral liquid sea cucumber cordyceps peptide according to claim 1, which is characterized in that: the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 30% of sea cucumber, 10% of medlar, 5% of ox kidney, 5% of ginseng, 5% of dwarf lilyturf tuber, 1% of dried orange peel, 0.3% of xylo-oligosaccharide, 0.1% of sodium carboxymethyl cellulose, 0.1% of potassium sorbate, 0.2% of cordyceps sinensis and 43.3% of pure water.
7. The oral liquid sea cucumber cordyceps peptide according to claim 1, which is characterized in that: the oral liquid sea cucumber cordyceps peptide consists of the following components in percentage by weight: 25 percent of sea cucumber, 13 percent of medlar, 6 percent of ox kidney, 7 percent of ginseng, 7 percent of dwarf lilyturf tuber, 0.5 percent of tangerine peel, 0.5 percent of xylo-oligosaccharide, 0.1 percent of sodium carboxymethyl cellulose, 0.1 percent of potassium sorbate, 0.2 percent of cordyceps sinensis and 40.6 percent of pure water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210081746.4A CN114377108A (en) | 2022-01-24 | 2022-01-24 | Oral liquid, sea cucumber and cordyceps peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210081746.4A CN114377108A (en) | 2022-01-24 | 2022-01-24 | Oral liquid, sea cucumber and cordyceps peptide |
Publications (1)
Publication Number | Publication Date |
---|---|
CN114377108A true CN114377108A (en) | 2022-04-22 |
Family
ID=81204146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210081746.4A Pending CN114377108A (en) | 2022-01-24 | 2022-01-24 | Oral liquid, sea cucumber and cordyceps peptide |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114377108A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331281A (en) * | 2000-06-26 | 2002-01-16 | 刘慎远 | Process for preparing medical wine |
CN203181942U (en) * | 2013-01-08 | 2013-09-11 | 百岳特生物科技(上海)有限公司 | Changbai ginseng particle structure capable of resisting fatigue and refreshing |
CN104611399A (en) * | 2015-01-27 | 2015-05-13 | 张恒 | Method for extracting sea cucumber polypeptide |
CN106974211A (en) * | 2017-05-25 | 2017-07-25 | 青岛银色世纪健康产业集团有限公司 | A kind of sea cucumber American ginseng medlar oral liquid of strengthen immunity and preparation method thereof |
-
2022
- 2022-01-24 CN CN202210081746.4A patent/CN114377108A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331281A (en) * | 2000-06-26 | 2002-01-16 | 刘慎远 | Process for preparing medical wine |
CN203181942U (en) * | 2013-01-08 | 2013-09-11 | 百岳特生物科技(上海)有限公司 | Changbai ginseng particle structure capable of resisting fatigue and refreshing |
CN104611399A (en) * | 2015-01-27 | 2015-05-13 | 张恒 | Method for extracting sea cucumber polypeptide |
CN106974211A (en) * | 2017-05-25 | 2017-07-25 | 青岛银色世纪健康产业集团有限公司 | A kind of sea cucumber American ginseng medlar oral liquid of strengthen immunity and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
仇微红等: "中药免疫调节作用的研究进展", 《广东畜牧兽医科技》 * |
杜玉枝: "虫草精口服液以膏定产生产工艺的探讨", 《青海医药杂志》 * |
赵兴坤: "海参肽的功能特性及其应用", 《中国食物与营养》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101238904B (en) | Chickpea bean sprout juice tea and preparation method and application | |
CN103976203B (en) | Jelly of a kind of beautifying face and moistering lotion and preparation method thereof | |
CN105039084A (en) | Banana composite fruit wine and manufacturing method thereof | |
CN106174205A (en) | A kind of fruit ferment and preparation method thereof | |
CN106615468A (en) | Golden camellia plant beverage for replenishing blood and maintaining beauty | |
CN106107735A (en) | A kind of preparation method of local flavor Caulis Cucurbitae | |
CN104304578A (en) | Pitaya fungus tea | |
CN108719968A (en) | A kind of composite enzyme and preparation method thereof | |
CN108210878A (en) | The cordyceps sinensis Saussurea Polysaccharide compound of kidney-tonifying sperm-generating | |
CN113632851A (en) | Multifunctional children growth milk powder and preparation method thereof | |
CN115428877A (en) | Beautifying and face nourishing sodium hyaluronate composite beverage and preparation method thereof | |
CN109329834A (en) | A kind of fructus lycii fatigue resistant health food and preparation method thereof | |
CN103976202B (en) | A kind of edible collagen protein jelly and preparation method thereof | |
CN111772194A (en) | Food formula for tonifying qi, soothing nerves, replenishing vital essence and reinforcing kidney | |
CN105999210A (en) | Lucid-ganoderma active lactobacillus preparation and preparing method | |
CN104287046A (en) | Biological beverage using peanuts as main raw materials and preparation method thereof | |
CN106889389A (en) | A kind of wild white bur oral liquid and preparation method thereof | |
CN107484984B (en) | Stichopus japonicus oral liquid rich in Stichopus japonicus active polysaccharide and its preparation method | |
CN1101471C (en) | Process for preparing active peptide of soybean protein | |
CN108498447A (en) | A kind of plant enzyme cleaning bubble liquid preparation | |
CN103976211B (en) | Jelly of a kind of fat-reducing and preparation method thereof | |
CN105395444A (en) | Method for preparing oyster facial mask | |
CN110771902A (en) | Composite polypeptide powder and application thereof | |
KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
CN109730222A (en) | Ferment complex liquid and its health drink |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220422 |
|
RJ01 | Rejection of invention patent application after publication |